Literature DB >> 30614483

Trifluridine/tipiracil in metastatic gastric cancer.

Zachary R McCaw1, Dae Hyun Kim2, Lu Tian1, Haoda Fu3, Lee-Jen Wei4.   

Abstract

Entities:  

Year:  2019        PMID： 30614483      PMCID： PMC7017585          DOI： 10.1016/S1470-2045(18)30908-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis.

Authors:  Hajime Uno; Brian Claggett; Lu Tian; Eisuke Inoue; Paul Gallo; Toshio Miyata; Deborah Schrag; Masahiro Takeuchi; Yoshiaki Uyama; Lihui Zhao; Hicham Skali; Scott Solomon; Susanna Jacobus; Michael Hughes; Milton Packer; Lee-Jen Wei
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

2.  Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Kohei Shitara; Toshihiko Doi; Mikhail Dvorkin; Wasat Mansoor; Hendrik-Tobias Arkenau; Aliaksandr Prokharau; Maria Alsina; Michele Ghidini; Catia Faustino; Vera Gorbunova; Edvard Zhavrid; Kazuhiro Nishikawa; Ayumu Hosokawa; Şuayib Yalçın; Kazumasa Fujitani; Giordano D Beretta; Eric Van Cutsem; Robert E Winkler; Lukas Makris; David H Ilson; Josep Tabernero
Journal:  Lancet Oncol       Date:  2018-10-21       Impact factor: 41.316

3.  Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies.

Authors:  Hajime Uno; Janet Wittes; Haoda Fu; Scott D Solomon; Brian Claggett; Lu Tian; Tianxi Cai; Marc A Pfeffer; Scott R Evans; Lee-Jen Wei
Journal:  Ann Intern Med       Date:  2015-07-21       Impact factor: 25.391

4.  Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.

Authors:  Kyongsun Pak; Hajime Uno; Dae Hyun Kim; Lu Tian; Robert C Kane; Masahiro Takeuchi; Haoda Fu; Brian Claggett; Lee-Jen Wei
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

5.  Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time.

Authors:  Zachary R McCaw; Ariela R Orkaby; Lee-Jen Wei; Dae Hyun Kim; Michael W Rich
Journal:  Am J Med       Date:  2018-08-01       Impact factor: 5.928
  5 in total
  1 in total

1.  CircPTK2 Suppresses the Progression of Gastric Cancer by Targeting the MiR-196a-3p/AATK Axis.

Authors:  Ling Gao; Tingting Xia; Mingde Qin; Xiaofeng Xue; Linhua Jiang; Xinguo Zhu
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.